University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy

Phase 1

Completed

Conditions: Glomerulonephritis

Interventions: Drug: Adrenocorticotrophic hormone ACTH

First Posted Date: 2010-03-25

Last Posted Date: 2017-05-04

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10

Registration Number: NCT01093157

Locations: 🇨🇦
University Health Network- Toronto General Hospital, Toronto, Ontario, Canada

Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction

Phase 1

Terminated

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cancer
Bowel Obstruction

Interventions: Drug: Cisplatin
Drug: Paclitaxel

First Posted Date: 2010-03-09

Last Posted Date: 2019-02-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1

Registration Number: NCT01083537

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer

Phase 2

Completed

Conditions: Thyroid Cancer

Interventions: Other: Decision aid exposure

First Posted Date: 2010-03-09

Last Posted Date: 2016-11-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 74

Registration Number: NCT01083550

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)

Phase 2

Terminated

Conditions: Graft Versus Host Disease

Interventions: Drug: Rituximab

First Posted Date: 2010-02-10

Last Posted Date: 2011-09-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1

Registration Number: NCT01066598

Locations: 🇨🇦
Alberta Health Sciences - Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada
🇨🇦
Princess Maragaret Hospital, Toronto, Ontario, Canada

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

Completed

Conditions: Bone Metastasis
Metastatic Prostate Cancer

First Posted Date: 2010-02-04

Last Posted Date: 2015-04-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 48

Registration Number: NCT01062503

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Assessment of Ovarian Reserve in Female Cancer Survivors

Completed

Conditions: Pediatric Cancer Survivor
Breast Cancer Survivor

Interventions: Procedure: Blood Draw and Ultrasound

First Posted Date: 2010-02-04

Last Posted Date: 2018-06-12

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 210

Registration Number: NCT01062542

Locations: 🇨🇦
University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

Phase 2

Completed

Conditions: Renal Cell Carcinoma

Interventions: Drug: Definity

First Posted Date: 2010-02-04

Last Posted Date: 2016-03-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 167

Registration Number: NCT01062178

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

The Effect of A-lipoic Acid (ALA) on Fatty Acid-induced Impairment of Glucose-stimulated Insulin Secretion

Phase 4

Completed

Conditions: Type 2 Diabetes
Prediabetes

Interventions: Drug: alpha lipoic acid

First Posted Date: 2010-01-26

Last Posted Date: 2012-10-02

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 15

Registration Number: NCT01056497

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

An Alternative to A Fixed Schedule In Management Of Prostate Cancer

Completed

Conditions: Prostate Cancer

First Posted Date: 2010-01-26

Last Posted Date: 2015-04-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 82

Registration Number: NCT01056562

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Effect of Remifentanil Boluses on Hemodynamics in Skull Pin Insertion

Not Applicable

Completed

Conditions: Short Duration Analgesia
Skull Pin Insertion

Interventions: Drug: Remifentanil

First Posted Date: 2010-01-26

Last Posted Date: 2010-01-26

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 72

Registration Number: NCT01056224

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy